| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9008466a40998f8be8e54cd3aceb10a2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1623
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 |
| filingDate |
2008-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e462818a0c69c5562e9fa6643f059f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0a11b1ed08ce3e4ea4d442f2b60036b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ec3348ea15314dc66586dca5ab36727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cdb3e0b2dfbae7f49df25e700ecf092 |
| publicationDate |
2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2568497-T3 |
| titleOfInvention |
Use of a composition comprising formoterol and beclomethasone dipropionate for the treatment of an asthma exacerbation |
| abstract |
Use of a composition comprising a fixed combination of a) formoterol, a pharmaceutically acceptable salt or solvate thereof or a solvate of said salt; and b) beclomethasone dipropionate; for the manufacture of a medicament administered by inhalation by means of a dry powder inhaler, formulated in the form of a dry powder composition comprising one or more suitable diluents or vehicles, or by means of a pressurized metered dose inhaler, in which both active ingredients (a) and (b) are completely dissolved in a liquid propellant mixture, for use in the treatment of acute asthma attack episodes, if necessary, as a complement to the maintenance treatment of asthma with the same medication. |
| priorityDate |
2007-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |